advertisement
Lappas A 10
Showing records 1 to 10 | Display all abstracts from Lappas A108071 Intraoperative primary partial occlusion of the PreserFlo MicroShunt to prevent initial postoperative hypotony
Lüke JN
International Ophthalmology 2023; 43: 2643-2651
108482 Predictability of success for combined iStent inject trabecular bypass implantation with phacoemulsification in the subsequent eye
Kiessling D; Rennings C
Clinical and Experimental Ophthalmology 2023; 51: 437-445
108071 Intraoperative primary partial occlusion of the PreserFlo MicroShunt to prevent initial postoperative hypotony
Reinking N; Dietlein TS
International Ophthalmology 2023; 43: 2643-2651
108482 Predictability of success for combined iStent inject trabecular bypass implantation with phacoemulsification in the subsequent eye
Hild M; Lappas A
Clinical and Experimental Ophthalmology 2023; 51: 437-445
108071 Intraoperative primary partial occlusion of the PreserFlo MicroShunt to prevent initial postoperative hypotony
Haendel A
International Ophthalmology 2023; 43: 2643-2651
108482 Predictability of success for combined iStent inject trabecular bypass implantation with phacoemulsification in the subsequent eye
Dietlein TS
Clinical and Experimental Ophthalmology 2023; 51: 437-445
108071 Intraoperative primary partial occlusion of the PreserFlo MicroShunt to prevent initial postoperative hypotony
Enders P
International Ophthalmology 2023; 43: 2643-2651
108482 Predictability of success for combined iStent inject trabecular bypass implantation with phacoemulsification in the subsequent eye
Roessler GF
Clinical and Experimental Ophthalmology 2023; 51: 437-445
108071 Intraoperative primary partial occlusion of the PreserFlo MicroShunt to prevent initial postoperative hypotony
Lappas A
International Ophthalmology 2023; 43: 2643-2651
108482 Predictability of success for combined iStent inject trabecular bypass implantation with phacoemulsification in the subsequent eye
Widder RA
Clinical and Experimental Ophthalmology 2023; 51: 437-445
